Erweiterte Funktionen


St. Jude Medical Withdraws FY16 Guidance Due To Merger With Abbott




19.10.16 13:42
dpa-AFX


WASHINGTON (dpa-AFX) - While reporting its financial results for the third quarter today, Medical device maker St. Jude Medical, Inc. (STJ) said it has withdrawn its financial guidance for fiscal 2016 due to its planned merger with Abbott Laboratories (ABT).


In April, Abbott said it has agreed to acquire St. Jude Medical. Under the agreement, St. Jude Medical shareholders will receive $46.75 in cash and 0.8708 shares of Abbott common stock, representing total consideration of approximately $85 per share. This represents a total transaction equity value of $25 billion.


Copyright RTT News/dpa-AFX



MMMM





 
 

Aktien des Tages
  


Mit der Anmeldung für den Newsletter "Aktien des Tages" stimme ich dem gleichzeitigen Erhalt des "GeVestor täglich" unseres Partners GeVestor zu.


Mit der Anmeldung für den Newsletter "Aktien des Tages" stimme ich dem gleichzeitigen Erhalt des "Investors Daily" unseres Partners FID Verlag zu.

RSS Feeds




Bitte warten...